AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Eupraxia Pharmaceuticals Inc.

$6.83 -$0.74 (-9.78%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$7.25
Day Range
$6.41$7.09
Year Range
$5.25$9.32
Market Cap
451.28M
AVG Volume
576.9K
Trailing/Forward PE
-6.68/-
PEG ratio
-0.16
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Net Income (USD) · A
-40M-30M-20M-10M0202020212022202320242025
EPRX Net Income (USD) by year
PeriodNet Income (USD)
2025-38.58M
2024-23.91M
2023-25.69M
2022-20.2M
2021-20.35M
2020-3.03M
Operating Income (USD) · A
-40M-30M-20M-10M0202020212022202320242025
EPRX Operating Income (USD) by year
PeriodOperating Income (USD)
2025-38.43M
2024-25.24M
2023-24.84M
2022-17.59M
2021-14.8M
2020-1.69M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: EPRX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.

Eupraxia Pharmaceuticals Inc.
EPRX
Stockpicker

Video analysis: EPRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EPRX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.